23andMe is a personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service enables individuals to gain deeper insights into their ancestry and genetic make-up. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research.
Company Growth (employees)
Type
Private
HQ
Mountain View, US
Founded
2006
Size (employees)
443 (est)+4%
23andMe was founded in 2006 and is headquartered in Mountain View, US

Key People/Management at 23andMe

Anne Wojcicki

Anne Wojcicki

CEO and Co-founder
Dean Schorno

Dean Schorno

CFO & Head of Operations
Angela Calman

Angela Calman

Vice President of Communications
Emily Drabant Conley

Emily Drabant Conley

Vice President of Business Development
Joyce Tung

Joyce Tung

Vice President of Research
Jonathan Ward

Jonathan Ward

Vice President, International
Kathy Hibbs

Kathy Hibbs

Chief Legal and Regulatory Officer
Steve Lemon

Steve Lemon

VP, Product & Engineering

23andMe Office Locations

23andMe has an office in Mountain View
Mountain View, US (HQ)
899 W Evelyn Ave

23andMe Financials and Metrics

Summary Metrics

23andMe's latest funding round in September 2017 was reported to be $250 m. In total, 23andMe has raised $486.1 m. 23andMe's latest valuation is reported to be $1.1 b.

23andMe Financials

USD

Market valuation

1.1 b
Show all financial metrics

23andMe Operating Metrics

23andMe's Customers was reported to be 2 m in 2017
Y, 2015Y, 2017

Customers

800 k2 m

Countries

50

Phenotypic Data Points Collected

600 m
Show all operating metrics

23andMe Median Salaries

Source: 13 public H-1B filings from 23andMe

Traffic Overview of 23andMe

23andMe Online and Social Media Presence

23andMe News and Updates

Women digital health CEOs big winners in 3rd-quarter funding

The average deal size for companies led by women CEOs was $31.4 million compared to $11.3 million for those with men CEOs in what is shaping up to be digital health’s biggest year of investments.

23andMe lands $250 million to expand do-it-yourself genetics testing

The startup has the only FDA authorization for direct-to-consumer genetic tests.

Sequoia co-leads $30 million investment in MedGenome’s research and diagnostics testing

MedGenome wants to develop research and diagnostics around rare diseases by looking at India’s population of 1.3 billion, and today the company announced funding of $30 million to further its mission. Sequoia Capital India and Sofina co-led the round, with participation from Zodius Capital and sever…

How predictive analytics helped reduce readmissions at UnityPoint Health

Engaging with different stakeholders and coaching care teams has helped the health system realize a 40 percent improvement in 30-day readmissions.

Former 23andMe president joins Livongo

Glen Tullman’s digital health startup, which helps people manage diabetes, has hired Any Page as CFO.

OIG scolds New Mexico for failing to secure Medicaid data

The state’s Human Services department migrated its legacy eligibility systems to a modernized network in 2014, but the Inspector General’s office found flaws caused by insufficient controls.
Show more

23andMe Company Life and Culture

You may also be interested in